Next Article in Journal
Venous Cannulation Pain as a Marker of Postoperative Pain Vulnerability: A Pre-Specified Secondary Analysis of a Randomized Controlled Trial
Previous Article in Journal
Sex-Specific Differences in Patients with Hypertrophic Cardiomyopathy: A Cohort Study from Vienna
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135

by
Saleh Althenayyan
1,2,
Mohammed H. AlMuhanna
1,2,
Abdulkareem AlAbdulrahman
2,3,
Bandar Alghanem
2,4,
Suliman A. Alsagaby
5,
Abdulaziz Alfahed
6,
Glowi Alasiri
7 and
Mohammad Azhar Aziz
1,2,8,*
1
Colorectal Cancer Research Program, Department of Cellular Therapy and Cancer Research, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia
2
King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia
3
Department of Medical Genomics, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia
4
Department of Core Facilities and Platforms, King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia
5
Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah 11932, Saudi Arabia
6
Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Alkharj 11942, Saudi Arabia
7
Department of Biochemistry, College of Medicine, Al Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia
8
Interdisciplinary Nanotechnology Center, Aligarh Muslim University, Aligarh 202002, India
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2026, 16(1), 57; https://doi.org/10.3390/jpm16010057 (registering DOI)
Submission received: 15 January 2026 / Accepted: 16 January 2026 / Published: 22 January 2026
Error in Figure 3
In the original publication [1], Figure 3B contained an incorrect schematic that did not represent ADAM12 alternative splicing as described in the manuscript. The figure legend is correct; the error was limited to the figure itself. The corrected Figure 3 (Alternative splicing of ADAM12 protein-coding isoforms) appears below.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Althenayyan, S.; AlMuhanna, M.H.; AlAbdulrahman, A.; Alghanem, B.; Alsagaby, S.A.; Alfahed, A.; Alasiri, G.; Aziz, M.A. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135. [Google Scholar] [CrossRef] [PubMed]
Figure 3. Sequence similarity analyses for ADAM12. (A): Sequence similarity of the five alternatively spliced isoforms of ADAM12. (B): Illustration of the exon organization of ADAM12 used to design primers for the specific amplification of alternatively spliced isoforms. The ADAM12 gene and isoforms are presented as horizontal lines. Each vertical bar represents an exon separated by intronic regions. The image shows the skipping of exon 14 in all isoforms and the pretermination of isoforms 2, 4 and 5.
Figure 3. Sequence similarity analyses for ADAM12. (A): Sequence similarity of the five alternatively spliced isoforms of ADAM12. (B): Illustration of the exon organization of ADAM12 used to design primers for the specific amplification of alternatively spliced isoforms. The ADAM12 gene and isoforms are presented as horizontal lines. Each vertical bar represents an exon separated by intronic regions. The image shows the skipping of exon 14 in all isoforms and the pretermination of isoforms 2, 4 and 5.
Jpm 16 00057 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Althenayyan, S.; AlMuhanna, M.H.; AlAbdulrahman, A.; Alghanem, B.; Alsagaby, S.A.; Alfahed, A.; Alasiri, G.; Aziz, M.A. Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135. J. Pers. Med. 2026, 16, 57. https://doi.org/10.3390/jpm16010057

AMA Style

Althenayyan S, AlMuhanna MH, AlAbdulrahman A, Alghanem B, Alsagaby SA, Alfahed A, Alasiri G, Aziz MA. Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135. Journal of Personalized Medicine. 2026; 16(1):57. https://doi.org/10.3390/jpm16010057

Chicago/Turabian Style

Althenayyan, Saleh, Mohammed H. AlMuhanna, Abdulkareem AlAbdulrahman, Bandar Alghanem, Suliman A. Alsagaby, Abdulaziz Alfahed, Glowi Alasiri, and Mohammad Azhar Aziz. 2026. "Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135" Journal of Personalized Medicine 16, no. 1: 57. https://doi.org/10.3390/jpm16010057

APA Style

Althenayyan, S., AlMuhanna, M. H., AlAbdulrahman, A., Alghanem, B., Alsagaby, S. A., Alfahed, A., Alasiri, G., & Aziz, M. A. (2026). Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135. Journal of Personalized Medicine, 16(1), 57. https://doi.org/10.3390/jpm16010057

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop